Global Generic Drugs Market 2018-2022

About Generic Drugs
A generic drug is a medication created to be the equivalent of an existing approved brand-name drug in terms of dosage form, safety, strength, route of administration, quality, and performance characteristics.
Technavio’s analysts forecast the Global Generic Drugs Market to grow at a CAGR of 10.22% during the period 2018-2022.

Covered in this report
The report covers the present scenario and the growth prospects of the generic drugs market. To calculate the market size, the report considers the revenue generated from the sales of generic drugs.

The market is divided into the following segments based on geography:
‧ Americas
‧ APAC
‧ EMEA

Technavio's report, generic drugs market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
‧ Fresenius Kabi
‧ Mylan
‧ Novartis
‧ Pfizer
‧ Sun Pharmaceutical Industries
‧ Teva Pharmaceutical Industries


Market driver
‧ Rising drug patient expirations
‧ For a full, detailed list, view our report
Market challenge
‧ Rising credibility issues
‧ For a full, detailed list, view our report

Market trend
‧ Rising M&A
‧ For a full, detailed list, view our report

Key questions answered in this report
‧ What will the market size be in 2022 and what will the growth rate be?
‧ What are the key market trends?
‧ What is driving this market?
‧ What are the challenges to market growth?
‧ Who are the key vendors in this market space?
‧ What are the market opportunities and threats faced by the key vendors?
‧ What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.